CGCP | JHS | CGCP / JHS | |
Gain YTD | 6.154 | 6.296 | 98% |
Net Assets | 5.66B | 146M | 3,875% |
Total Expense Ratio | 0.34 | 1.66 | 20% |
Turnover | 83.00 | 72.00 | 115% |
Yield | 5.06 | 4.76 | 106% |
Fund Existence | 4 years | 53 years | - |
CGCP | JHS | |
---|---|---|
RSI ODDS (%) | 3 days ago46% | 3 days ago69% |
Stochastic ODDS (%) | 3 days ago42% | 3 days ago75% |
Momentum ODDS (%) | 3 days ago58% | 3 days ago83% |
MACD ODDS (%) | 3 days ago64% | 3 days ago70% |
TrendWeek ODDS (%) | 3 days ago64% | 3 days ago83% |
TrendMonth ODDS (%) | 3 days ago63% | 3 days ago79% |
Advances ODDS (%) | 3 days ago58% | 10 days ago81% |
Declines ODDS (%) | 6 days ago54% | N/A |
BollingerBands ODDS (%) | 3 days ago43% | 3 days ago64% |
Aroon ODDS (%) | 3 days ago70% | 3 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SBIO | 37.01 | 0.86 | +2.37% |
ALPS Medical Breakthroughs ETF | |||
RQI | 12.63 | 0.18 | +1.45% |
COHEN & STEERS QUALITY Income REALTY FUND | |||
FEBP | 30.47 | N/A | N/A |
PGIM S&P 500 Buffer 12 ETF - Feb | |||
LIAV | 237.69 | N/A | N/A |
LifeX 2061 Infl-Prt Longevity Inc ETF | |||
SPXX | 18.16 | -0.09 | -0.49% |
Nuveen S&P 500 Dynamic Overwrite Fund |
A.I.dvisor tells us that CGCP and NFE have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGCP and NFE's prices will move in lockstep.
Ticker / NAME | Correlation To CGCP | 1D Price Change % | ||
---|---|---|---|---|
CGCP | 100% | +0.40% | ||
NFE - CGCP | 5% Poorly correlated | +4.26% |